SORBITAN TRISTEARATE
CAS26658-19-5
SORBITAN TRISTEARATE (CAS 26658-19-5, C60H114O8) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 26658-19-5
- Formula
- C60H114O8
- Mol. weight
- 963.54 g/mol
- Appearance
- a light cream to tan-coloured, hard, waxy solid with a slight characteristic odour and bland taste
Chemical Specifications
Identifiers
| CAS number | 26658-19-5 |
|---|---|
| Product name | SORBITAN TRISTEARATE |
| Synonyms | SORBITAN TRISTEARATE |
| Molecular formula | C60H114O8 |
| Molecular weight | 963.54 g/mol |
| EC number | 247-891-4 |
Physical and chemical properties
| Appearance | a light cream to tan-coloured, hard, waxy solid with a slight characteristic odour and bland taste |
|---|---|
| Boiling Point | 231.6 ( ℃ ) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of SORBITAN TRISTEARATE?
The CAS Registry Number of SORBITAN TRISTEARATE is 26658-19-5. SORBITAN TRISTEARATE is also known as SORBITAN TRISTEARATE.
What is the molecular formula and molecular weight of SORBITAN TRISTEARATE?
The molecular formula of SORBITAN TRISTEARATE is C60H114O8, and its molecular weight is 963.54 g/mol.
How can I request a quotation for SORBITAN TRISTEARATE?
Send an inquiry for SORBITAN TRISTEARATE (CAS 26658-19-5) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for SORBITAN TRISTEARATE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.